Control of  -aminolevulinic acid synthetase and tyrosine aminotransferase in tumors and livers of tumor-bearing rats.
D000624:5-Aminolevulinate Synthetase / Q000037:antagonists & inhibitors / Q000378:metabolism*; D000418:Albumins / Q000032:analysis; D000502:Allylisopropylacetamide / Q000494:pharmacology; D000818:Animals; D002273:Carcinogens; D002279:Carcinoma 256, Walker / Q000201:enzymology; D006528:Carcinoma, Hepatocellular / Q000201:enzymology; D004790:Enzyme Induction / Q000187:drug effects; D005260:Female; D005354:Fibrosarcoma / Q000201:enzymology; D006207:Half-Life; D006466:Hemopexin / Q000032:analysis; D066298:In Vitro Techniques; D008099:Liver / Q000201:enzymology*; D008113:Liver Neoplasms / Q000201:enzymology; D008930:Mitochondria, Liver / Q000201:enzymology; D009374:Neoplasms, Experimental / Q000139:chemically induced / Q000201:enzymology*; D051381:Rats; D011919:Rats, Inbred Strains; D013997:Time Factors; D014444:Tyrosine Transaminase / Q000378:metabolism*
D000418:Albumins; D002273:Carcinogens; D000502:Allylisopropylacetamide; D006466:Hemopexin; D000624:5-Aminolevulinate Synthetase; D014444:Tyrosine Transaminase